在血液生物标志物检测和神经成像中对帕金森病的当前趋势
Ni Liu1, Tianjiao Zhang1, Wei Zhao1
1College of Public Health, Zhengzhou University, Zhengzhou 450001, China.
Ageing research reviews
|January 10, 2025
概括
帕金森病的诊断面临挑战,原因是生物标志物不明确和进展变化. 本综述探讨了血液生物标志物检测技术,强调了多模式方法的必要性,以提高准确性和个性化医疗.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物发现发现
- 医学诊断 医学诊断 医学诊断
背景情况:
- 帕金森病 (PD) 呈现出运动和认知症状,并由不可预测的进展而复杂化.
- 目前的诊断局限性源于缺乏明确的生物标志物和有效的早期检测/成像方法.
- 准确的PD生物标志物对于诊断,患者分层和监测疾病进展至关重要.
研究的目的:
- 审查帕金森病血液生物标志物检测技术的发展趋势.
- 讨论多式联络生物标志物和光学/成像技术的整合,以改善PD诊断.
- 为了指导未来的研究和PD血液检测的临床实施.
主要方法:
- 审查最近在PD生物标志物检测技术的进展.
- 对生物标志物识别的光学分析平台的分析.
- 讨论多式联运生物标志物整合策略.
主要成果:
- 尽管有进展,但目前的PD生物标志物表现出低于最佳的特异性和敏感性.
- 与脑脊液分析相比,血液检测为生物标志物采购提供了一个不那么侵入性的替代方案.
- 新兴的光学和成像技术显示了提高PD检测的希望.
结论:
- 将多式联络生物标志物与先进的光学和成像技术相结合,是提高PD诊断准确性的关键.
- 增强的诊断工具将促进帕金森病的个性化医疗方法.
- 需要进一步的研究来完善临床实践中的生物标志物实施.
相关概念视频
Parkinson's Disease: Overview
472
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
472
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Parkinson's Disease: Treatment
215
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
215


